SYDNEY MEADOWS: Open Payments
NPI 1396361473 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 10 payments from 6 companies in 2025. Trend: 2023 $148 · 2024 $70 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $104 |
| Neurocrine BioSciences, Inc. | 1 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
